Related Experiment Video
Updated: Aug 1, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
A natural variation-based screen in mouse cells reveals USF2 as a regulator of the DNA damage response and cellular
Taekyu Kang1,2, Emily C Moore3, Emily E K Kopania3
1Buck Institute for Research on Aging, Novato, CA 94945, USA.
Abstract:
Cellular senescence is a program of cell cycle arrest, apoptosis resistance, and cytokine release induced by stress exposure in metazoan cells. Landmark studies in laboratory mice have characterized a number of master senescence regulators, including p16INK4a, p21, NF-κB, p53, and C/EBPβ. To discover other molecular players in senescence, we developed a screening approach to harness the evolutionary divergence between mouse species. We found that primary cells from the Mediterranean mouse Mus spretus, when treated with DNA damage to induce senescence, produced less cytokine and had less-active lysosomes than cells from laboratory Mus musculus. We used allele-specific expression profiling to catalog senescence-dependent cis-regulatory variation between the species at thousands of genes. We then tested for correlation between these expression changes and interspecies sequence variants in the binding sites of transcription factors. Among the emergent candidate senescence regulators, we chose a little-studied cell cycle factor, upstream stimulatory factor 2 (USF2), for molecular validation. In acute irradiation experiments, cells lacking USF2 had compromised DNA damage repair and response. Longer-term senescent cultures without USF2 mounted an exaggerated senescence regulatory program-shutting down cell cycle and DNA repair pathways, and turning up cytokine expression, more avidly than wild-type. We interpret these findings under a model of pro-repair, anti-senescence regulatory function by USF2. Our study affords new insights into the mechanisms by which cells commit to senescence, and serves as a validated proof of concept for natural variation-based regulator screens.
Insights
Upstream stimulatory factor 2 (USF2) helps repair DNA damage and prevents excessive cellular senescence. This discovery offers new insights into senescence regulation and identifies USF2 as a key factor.
Area of Science:
- Cellular and Molecular Biology
- Genetics and Genomics
- Aging Research
Background:
- Cellular senescence is a stress-induced cell cycle arrest with implications for aging and disease.
- Known regulators include p16INK4a, p21, NF-κB, p53, and C/EBPβ.
- Identifying novel senescence regulators is crucial for understanding cellular aging mechanisms.
Purpose of the Study:
- To discover novel molecular regulators of cellular senescence using evolutionary divergence between mouse species.
- To investigate the role of upstream stimulatory factor 2 (USF2) in senescence.
- To elucidate the function of USF2 in DNA damage response and senescence.
Main Methods:
- Developed a screening approach leveraging genetic variation between Mus spretus and Mus musculus.
- Utilized allele-specific expression profiling to identify senescence-dependent cis-regulatory variation.
- Performed molecular validation of candidate regulators, focusing on USF2, through gene knockout and cellular assays.
Main Results:
- Mus spretus cells showed reduced cytokine production and lysosomal activity during senescence compared to Mus musculus.
- USF2-deficient cells exhibited impaired DNA damage repair and response.
- Loss of USF2 led to an exaggerated senescence program, including accelerated cell cycle arrest and increased cytokine expression.
Conclusions:
- USF2 functions as a pro-repair, anti-senescence regulator.
- This study provides new insights into the commitment mechanisms of cellular senescence.
- Natural variation-based screening is a validated approach for discovering regulator genes.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Replicative Cell Senescence

